FUNDACION PUBLICA GALEGA INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA

Their core work

FIDIS is the public health research institute of the Santiago de Compostela university hospital system in Galicia, Spain. They conduct clinical and translational research spanning radiotherapy dosimetry, infectious disease diagnostics, and cardiovascular prevention. Their core contribution to EU projects is access to clinical data, patient cohorts, and hospital-embedded research infrastructure. As a third-party contributor to larger consortia, they typically provide clinical validation and real-world patient evidence for diagnostic and digital health platforms.

What they specialise in

How they've shifted over time

FIDIS entered H2020 in 2019 with a focused Marie Curie fellowship in radiotherapy dosimetry (TRIDOS), indicating strength in medical physics and nuclear medicine. From 2020 onward, their involvement shifted toward large-scale clinical innovation projects in infectious disease diagnostics (DIAMONDS) and digital cardiology platforms (TIMELY). This trajectory suggests a move from individual researcher training toward contributing clinical infrastructure to multi-partner translational health projects.

FIDIS is expanding from niche medical physics research toward broader clinical participation in diagnostic and digital health consortia, making them a growing source of clinical validation capacity in Spain.

How they like to work

FIDIS primarily participates as a third-party contributor linked to larger partner institutions, meaning they provide specialized clinical input without bearing full consortium obligations. Their 45 unique partners across 13 countries come from involvement in large-scale health consortia (DIAMONDS and TIMELY), not from leading many projects. This makes them a low-overhead clinical partner — useful for consortia needing Spanish hospital-based research sites without heavy administrative burden.

Through their participation in two large health consortia, FIDIS connects with 45 partners across 13 countries, giving them a broad European network despite their modest direct project count. Their geographic reach reflects the pan-European nature of clinical trials and diagnostic validation studies.

What sets them apart

FIDIS offers something specific: a publicly funded Galician health research institute embedded in the Santiago de Compostela hospital system, providing direct access to clinical environments and patient populations. Their combination of medical physics expertise (radiotherapy dosimetry) and clinical diagnostics capacity is uncommon for a single institute. For consortium builders, they represent a reliable Spanish clinical site with emerging experience in EU project participation.

Highlights from their portfolio

• TRIDOS
  Their only coordinated project — a Marie Curie fellowship in radiotherapy dosimetry, showing independent research leadership in medical physics.
• DIAMONDS
  Large-scale Innovation Action (2020-2026) developing RNA-based diagnostics for febrile illness, connecting FIDIS to a major EU infectious disease initiative.